Cargando…
P1131: POST HOC ANALYSIS OF PATIENTS WITH HIGHLY PROLIFERATIVE VARIANTS OF MANTLE CELL LYMPHOMA TREATED WITH ACALABRUTINIB
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430145/ http://dx.doi.org/10.1097/01.HS9.0000847392.35657.0d |
| _version_ | 1784779672299503616 |
|---|---|
| author | Le Gouill, S. Długosz-Danecka, M. Rule, S. Luigi Zinzani, P. Goy, A. Smith, S. D. Doorduijn, J. K. Panizo, C. Shah, B. Davies, A. Eek, R. Jacobsen, E. Kater, A. P. Robak, T. Jain, P. Calvo, R. Yang, H. Wang, M. |
| author_facet | Le Gouill, S. Długosz-Danecka, M. Rule, S. Luigi Zinzani, P. Goy, A. Smith, S. D. Doorduijn, J. K. Panizo, C. Shah, B. Davies, A. Eek, R. Jacobsen, E. Kater, A. P. Robak, T. Jain, P. Calvo, R. Yang, H. Wang, M. |
| author_sort | Le Gouill, S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430145 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94301452022-08-31 P1131: POST HOC ANALYSIS OF PATIENTS WITH HIGHLY PROLIFERATIVE VARIANTS OF MANTLE CELL LYMPHOMA TREATED WITH ACALABRUTINIB Le Gouill, S. Długosz-Danecka, M. Rule, S. Luigi Zinzani, P. Goy, A. Smith, S. D. Doorduijn, J. K. Panizo, C. Shah, B. Davies, A. Eek, R. Jacobsen, E. Kater, A. P. Robak, T. Jain, P. Calvo, R. Yang, H. Wang, M. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430145/ http://dx.doi.org/10.1097/01.HS9.0000847392.35657.0d Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Le Gouill, S. Długosz-Danecka, M. Rule, S. Luigi Zinzani, P. Goy, A. Smith, S. D. Doorduijn, J. K. Panizo, C. Shah, B. Davies, A. Eek, R. Jacobsen, E. Kater, A. P. Robak, T. Jain, P. Calvo, R. Yang, H. Wang, M. P1131: POST HOC ANALYSIS OF PATIENTS WITH HIGHLY PROLIFERATIVE VARIANTS OF MANTLE CELL LYMPHOMA TREATED WITH ACALABRUTINIB |
| title | P1131: POST HOC ANALYSIS OF PATIENTS WITH HIGHLY PROLIFERATIVE VARIANTS OF MANTLE CELL LYMPHOMA TREATED WITH ACALABRUTINIB |
| title_full | P1131: POST HOC ANALYSIS OF PATIENTS WITH HIGHLY PROLIFERATIVE VARIANTS OF MANTLE CELL LYMPHOMA TREATED WITH ACALABRUTINIB |
| title_fullStr | P1131: POST HOC ANALYSIS OF PATIENTS WITH HIGHLY PROLIFERATIVE VARIANTS OF MANTLE CELL LYMPHOMA TREATED WITH ACALABRUTINIB |
| title_full_unstemmed | P1131: POST HOC ANALYSIS OF PATIENTS WITH HIGHLY PROLIFERATIVE VARIANTS OF MANTLE CELL LYMPHOMA TREATED WITH ACALABRUTINIB |
| title_short | P1131: POST HOC ANALYSIS OF PATIENTS WITH HIGHLY PROLIFERATIVE VARIANTS OF MANTLE CELL LYMPHOMA TREATED WITH ACALABRUTINIB |
| title_sort | p1131: post hoc analysis of patients with highly proliferative variants of mantle cell lymphoma treated with acalabrutinib |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430145/ http://dx.doi.org/10.1097/01.HS9.0000847392.35657.0d |
| work_keys_str_mv | AT legouills p1131posthocanalysisofpatientswithhighlyproliferativevariantsofmantlecelllymphomatreatedwithacalabrutinib AT długoszdaneckam p1131posthocanalysisofpatientswithhighlyproliferativevariantsofmantlecelllymphomatreatedwithacalabrutinib AT rules p1131posthocanalysisofpatientswithhighlyproliferativevariantsofmantlecelllymphomatreatedwithacalabrutinib AT luigizinzanip p1131posthocanalysisofpatientswithhighlyproliferativevariantsofmantlecelllymphomatreatedwithacalabrutinib AT goya p1131posthocanalysisofpatientswithhighlyproliferativevariantsofmantlecelllymphomatreatedwithacalabrutinib AT smithsd p1131posthocanalysisofpatientswithhighlyproliferativevariantsofmantlecelllymphomatreatedwithacalabrutinib AT doorduijnjk p1131posthocanalysisofpatientswithhighlyproliferativevariantsofmantlecelllymphomatreatedwithacalabrutinib AT panizoc p1131posthocanalysisofpatientswithhighlyproliferativevariantsofmantlecelllymphomatreatedwithacalabrutinib AT shahb p1131posthocanalysisofpatientswithhighlyproliferativevariantsofmantlecelllymphomatreatedwithacalabrutinib AT daviesa p1131posthocanalysisofpatientswithhighlyproliferativevariantsofmantlecelllymphomatreatedwithacalabrutinib AT eekr p1131posthocanalysisofpatientswithhighlyproliferativevariantsofmantlecelllymphomatreatedwithacalabrutinib AT jacobsene p1131posthocanalysisofpatientswithhighlyproliferativevariantsofmantlecelllymphomatreatedwithacalabrutinib AT katerap p1131posthocanalysisofpatientswithhighlyproliferativevariantsofmantlecelllymphomatreatedwithacalabrutinib AT robakt p1131posthocanalysisofpatientswithhighlyproliferativevariantsofmantlecelllymphomatreatedwithacalabrutinib AT jainp p1131posthocanalysisofpatientswithhighlyproliferativevariantsofmantlecelllymphomatreatedwithacalabrutinib AT calvor p1131posthocanalysisofpatientswithhighlyproliferativevariantsofmantlecelllymphomatreatedwithacalabrutinib AT yangh p1131posthocanalysisofpatientswithhighlyproliferativevariantsofmantlecelllymphomatreatedwithacalabrutinib AT wangm p1131posthocanalysisofpatientswithhighlyproliferativevariantsofmantlecelllymphomatreatedwithacalabrutinib |